FDA Announces Approval of Information Collection on Direct-to-Consumer Promotion of Prescription Drugs

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information on physician and patient attitudes toward direct-to-consumer promotion of prescription drugs, as required by the Paperwork Reduction Act of 1995.